// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Investigating unilateral pleural effusions: the role of cytology.

David Arnold - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease

Louise Wain - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Multicenter review suggests tunneled pleural catheter use in antineoplastic therapy-related immunosuppression does not increase infection rate

Candice Wilshire - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Osteoporosis onset in patients prescribed ICS for COPD: matched cohort study

David Price - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Osteoporosis

N/A

Developing an integrated pleural service

Elizabeth Batalla-Duran - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The DIAPHRAGM study: Diagnostic and prognostic biomarkers in the rational assessment of Mesothelioma

Selina Tsim - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Mesothelioma

N/A

Eligibility for lung volume reduction surgery in COPD patients identified in a UK primary care setting

Olivia Connell - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The impact of a dedicated multidisciplinary social media team at a national critical care conference

Rachael Moses - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS

Norbert Krug - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

RV16UB

Eosinophils as a predictor of mepolizumab treatment responses in COPD

Ian Douglas Pavord - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Mepolizumab

Transcriptional Signature Identifies Phenotypic Heterogeneity of Human Tuberculosis Infection

Raman Verma - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Airborne exposures and fractional exhaled nitric oxide in British foundry workers

Ruth Wiggans - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Atopic hypersensitivity

Nitric oxide

Outcomes post hip fracture for patients with COPD

Lewis Buss - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Trauma

N/A

Association between ICS therapy for COPD and diabetes onset and progression

Jaco Voorham - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Type 2 diabetes mellitus

N/A

Evidence based Code of Best Practice for animal research facilities: results of the SPIRAL study

Johanna Feary - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Glycaemic variability indices are associated with increased pulmonary function decline in people with cystic fibrosis

Freddy Frost - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: Qualitative interviews with health care professionals from the pilot phase

Clarisse Dibao-Dina - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Does intraocular pressure change in response to CPAP applied in wakefulness?

Dariusz Wozniak - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Primary open angle glaucoma

N/A

Can exposure to nitrogen dioxide concentration be reduced by a simple action plan?

Lee Koh - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG) in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD).

Samantha Pilsworth - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved